Blood Group (ABO) and Rhesus Factor

ABO and Rhesus factor are systems used to classify your blood based on specific proteins—called antigens—that sit on the surface of your red blood cells. These antigens are inherited from your parents and remain stable for life. The ABO system divides blood into four main types: A, B, AB, and O, depending on which antigens are present. Type A has A antigens, type B has B antigens, type AB carries both, and type O carries neither. The Rhesus (Rh) system determines whether you have another antigen called Rh D. If you have it, you are Rh-positive; if not, you are Rh-negative.

These two systems are essential because they determine whether one person’s blood is compatible with another's. If incompatible blood is transfused, the immune system can react aggressively, causing dangerous complications. This is why hospitals always check ABO and Rh type before transfusions, surgeries, or organ transplants.

In pregnancy, Rh factor plays a unique role. An Rh-negative mother carrying an Rh-positive baby may form antibodies against the baby’s red blood cells—a process known as Rh alloimmunization. Without medical prevention, these antibodies can affect future pregnancies. A special injection called Rh immunoglobulin is used in these cases, as recommended by major obstetric guidelines, to prevent the mother from forming harmful antibodies.

Understanding your ABO group and Rh factor is important for several major aspects of health. First and most critically, it ensures safe blood transfusions. If your blood type is incompatible with donated blood, your immune system can attack the transfused cells, causing serious and potentially life-threatening reactions. For example, people with type O—who lack A and B antigens—can only receive type O blood, while people with type AB can receive A, B, AB, or O. Knowing your ABO type allows emergency teams to act quickly and safely.

Rh factor becomes especially important during pregnancy. If an Rh-negative woman becomes pregnant with an Rh-positive baby, her immune system may begin producing antibodies against Rh-positive cells. This does not usually affect the first pregnancy, but in later pregnancies these antibodies can cross the placenta and harm the baby’s red blood cells. Fortunately, modern medical care prevents this through the use of Rh immunoglobulin, given during and after pregnancy to stop antibody formation. This has significantly reduced complications and is a cornerstone of prenatal care.

1. Al-Kuran, O., Al-Mehaisen, L., Qasem, R., et al. (2023). Distribution of ABO and Rh blood groups among pregnant women. Scientific Reports, 13, 13196. https://doi.org/10.1038/s41598-023-40085-w

2. American College of Obstetricians and Gynecologists. (2017). Practice Bulletin No. 181: Prevention of Rh D alloimmunization. Obstetrics & Gynecology, 130(2), e57–e70. https://doi.org/10.1097/AOG.0000000000002232

3. Fasano, R. M., & Chou, S. T. (2016). RBC antigen genotyping. Transfusion Medicine Reviews, 30(4), 197–201. https://doi.org/10.1016/j.tmrev.2016.05.011

4. Poole, J., & Daniels, G. (2007). Blood group antibodies and their significance in transfusion medicine. Transfusion Medicine Reviews, 21(1), 58–71. https://doi.org/10.1016/j.tmrv.2006.08.003

5. Sandler, S. G., & Queenan, J. T. (2017). A guide to terminology for Rh immunoprophylaxis. Obstetrics & Gynecology, 130(3), 633–635. https://doi.org/10.1097/AOG.0000000000002190

6. American Academy of Family Physicians. (2023). Prenatal care: An evidence-based approach.

7. Abegaz, S. B. (2021). Human ABO blood groups and their associations with different diseases. BioMed Research International, 2021, 6629060. https://doi.org/10.1155/2021/6629060

8. Bruun-Rasmussen, P., Hanefeld Dziegiel, M., Banasik, K., Johansson, P. I., & Brunak, S. (2023). Associations of ABO and Rhesus D blood groups with phenome-wide disease incidence: A 41-year retrospective cohort study of 482,914 patients. eLife, 12, e83116. https://doi.org/10.7554/eLife.83116

9. Dahlén, T., Clements, M., Zhao, J., Olsson, M. L., & Edgren, G. (2021). An agnostic study of associations between ABO and RhD blood group and phenome-wide disease risk. eLife, 10, e65658. https://doi.org/10.7554/eLife.65658

10. Liu, F. H., Guo, J. K., Xing, W. Y., et al. (2024). ABO and Rhesus blood groups and multiple health outcomes: An umbrella review of systematic reviews with meta-analyses of observational studies. BMC Medicine, 22, 206. https://doi.org/10.1186/s12916-024-03423-x

11. Groot, H. E., Villegas Sierra, L. E., Said, M. A., et al. (2020). Genetically determined ABO blood group and its associations with health and disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 40(3), 830–838. https://doi.org/10.1161/ATVBAHA.119.313658

12. Gotsman, I., Keren, A., Zwas, D. R., Lotan, C., & Admon, D. (2018). Clinical impact of ABO and Rhesus D blood type groups in patients with chronic heart failure. American Journal of Cardiology, 122(3), 413–419. https://doi.org/10.1016/j.amjcard.2018.04.018

13. Abuawwad, M. T., Taha, M. J. J., Abu-Ismail, L., et al. (2022). Effects of ABO blood groups and Rh-factor on COVID-19 transmission, course and outcome: A review. Frontiers in Medicine, 9, 1045060. https://doi.org/10.3389/fmed.2022.1045060